Brief: Suven Pharmaceuticals Approved Scheme Of Amalgamation Of Cohance Lifesciences Into And With Co
Feb 29 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* SUVEN PHARMACEUTICALS LTD - APPROVED SCHEME OF
AMALGAMATION OF
COHANCE LIFESCIENCES INTO AND WITH CO
Source text for Eikon: ID:nBSE3fxld6
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss